Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Claes

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Therapeutic Drug Monitoring|July 29, 2003
Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipientsD R J Kuypers, K Claes, P Evenepoel, et al.
Molecular Medicine Reports|July 5, 2011
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivityA Vral, P Willems, K Claes, et al.
The British Journal of Dermatology|October 19, 2007
Another devastating complication of the Schnitzler syndrome: AA amyloidosisK Claes, B Bammens, M Delforge, et al.
Clinical Nephrology|March 3, 2006
Hypertensive brain stem encephalopathy in a patient with chronic renal failureL Meylaerts, V Ooms, S Lyra, et al.
Genetic Counseling (Geneva, Switzerland)|July 26, 2014
A vestibular schwannoma in a patient with Birt-Hogg-Dube syndromeL De Keyzer, E M R De Leenheer, K Claes, et al.
Acta Gastro-Enterologica Belgica|March 3, 2024
STEC colitis mimicking acute severe colitis with life-threatening consequences: a case reportT Hendrickx, M Peetermans, A D'Hoore, et al.
International Journal of Radiation Biology|April 1, 2005
Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriersA Baeyens, H Thierens, K Claes, et al.
Annals of the Rheumatic Diseases|April 16, 2009
Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritisT Keersmaekers, K Claes, D R Kuypers, et al.
Disease Markers|December 14, 1999
Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > GK Claes, E Machackova, M De Vos, et al.
Human Mutation|March 25, 1999
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. OnlineK Claes, E Machackova, M De Vos, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Therapeutic Drug Monitoring|July 29, 2003
Long-term pharmacokinetic study of the novel combination of tacrolimus and sirolimus in de novo renal allograft recipientsD R J Kuypers, K Claes, P Evenepoel, et al.
Molecular Medicine Reports|July 5, 2011
Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivityA Vral, P Willems, K Claes, et al.
The British Journal of Dermatology|October 19, 2007
Another devastating complication of the Schnitzler syndrome: AA amyloidosisK Claes, B Bammens, M Delforge, et al.
Clinical Nephrology|March 3, 2006
Hypertensive brain stem encephalopathy in a patient with chronic renal failureL Meylaerts, V Ooms, S Lyra, et al.
Genetic Counseling (Geneva, Switzerland)|July 26, 2014
A vestibular schwannoma in a patient with Birt-Hogg-Dube syndromeL De Keyzer, E M R De Leenheer, K Claes, et al.
Acta Gastro-Enterologica Belgica|March 3, 2024
STEC colitis mimicking acute severe colitis with life-threatening consequences: a case reportT Hendrickx, M Peetermans, A D'Hoore, et al.
International Journal of Radiation Biology|April 1, 2005
Chromosomal radiosensitivity in BRCA1 and BRCA2 mutation carriersA Baeyens, H Thierens, K Claes, et al.
Annals of the Rheumatic Diseases|April 16, 2009
Long-term efficacy of infliximab treatment for AA-amyloidosis secondary to chronic inflammatory arthritisT Keersmaekers, K Claes, D R Kuypers, et al.
Disease Markers|December 14, 1999
Mutation analysis of the BRCA1 and BRCA2 genes in the Belgian patient population and identification of a Belgian founder mutation BRCA1 IVS5 + 3A > GK Claes, E Machackova, M De Vos, et al.
Human Mutation|March 25, 1999
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. OnlineK Claes, E Machackova, M De Vos, et al.
Pageof 6